Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCT200 and Chemotherapy in Recurrent/Metastatic HNSCC
NCT03874741Phase 2Unknown
- Sponsor
- Sinocelltech Group Limited
- Start
- May 2019
- Primary completion
- Jun 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sct200 in head and neck squamous cell carcinoma (HNSCC), sponsored by Sinocelltech Group Limited. Status: unknown.
02
Drugs
sct200
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT03874741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03874741.